Page last updated: 2024-08-17

androstenedione and Bone Loss, Perimenopausal

androstenedione has been researched along with Bone Loss, Perimenopausal in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgfeldt, C; Moberg, L; Nilsson, PM; Samsioe, G1
Camdeviren, H; Dilek, S; Ertunc, D; Oz, U; Ozdemir, G; Tok, EC1
Flanagan, AM; Lea, CK; Moxham, V; Reed, MJ1
Delmas, PD; Pearce, G; Ryan, PF; Seeman, E; Tabensky, DA1
Arlot, ME; Chapurlat, RD; Claustrat, B; Delmas, PD; Garnero, P; Sornay-Rendu, E1
Enzelsberger, H; Heytmanek, G; Kurz, C; Metka, M1
Birkenhäger, JC; De Jong, FH; Valkenburg, HA; van Hemert, AM; Vandenbroucke, JP1

Trials

1 trial(s) available for androstenedione and Bone Loss, Perimenopausal

ArticleYear
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
    British journal of rheumatology, 1998, Volume: 37, Issue:3

    Topics: Aged; Alkaline Phosphatase; Androstenedione; Anti-Inflammatory Agents; Bone and Bones; Bone Density; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal; Polymyalgia Rheumatica; Prednisolone; Prospective Studies

1998

Other Studies

6 other study(ies) available for androstenedione and Bone Loss, Perimenopausal

ArticleYear
Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.
    Maturitas, 2013, Volume: 75, Issue:3

    Topics: Androstenedione; Estradiol; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors; Sex Hormone-Binding Globulin; Women's Health

2013
The effect of circulating androgens on bone mineral density in postmenopausal women.
    Maturitas, 2004, Jul-15, Volume: 48, Issue:3

    Topics: Adult; Aged; Androgens; Androstenedione; Bone Density; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Radioimmunoassay; Regression Analysis; Testosterone

2004
Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.
    The Journal of endocrinology, 1998, Volume: 156, Issue:2

    Topics: Androstenedione; Animals; Bone Remodeling; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone

1998
Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2000, Volume: 11, Issue:6

    Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Androstenedione; Bone Density; Collagen; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Longitudinal Studies; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Procollagen; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone

2000
[The effects of smoking on estrogen level and bone mass].
    Gynakologische Rundschau, 1989, Volume: 29 Suppl 2

    Topics: Adult; Androstenedione; Bone Density; Dehydroepiandrosterone; Estradiol; Estrogens; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Smoking

1989
Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens.
    Clinical endocrinology, 1989, Volume: 31, Issue:4

    Topics: Androstenedione; Body Height; Body Weight; Bone and Bones; Estradiol; Estrogens; Estrone; Female; Fractures, Bone; Humans; Metacarpus; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors; Sex Hormone-Binding Globulin

1989